These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17354342)

  • 1. Assay to detect H5N1 oseltamivir resistance.
    Suwannakarn K; Chutinimitkul S; Payungporn S; Chieochansin T; Theamboonlers A; Amonsin A; Damrongwatanapokin S; Mai le Q; Hanh NH; Poovorawan Y
    Emerg Infect Dis; 2006 Dec; 12(12):1995-6. PubMed ID: 17354342
    [No Abstract]   [Full Text] [Related]  

  • 2. Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt.
    Earhart KC; Elsayed NM; Saad MD; Gubareva LV; Nayel A; Deyde VM; Abdelsattar A; Abdelghani AS; Boynton BR; Mansour MM; Essmat HM; Klimov A; Shuck-Lee D; Monteville MR; Tjaden JA
    J Infect Public Health; 2009; 2(2):74-80. PubMed ID: 20701864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oseltamivir resistance in influenza A (H5N1) infection.
    Gupta RK; Nguyen-Van-Tam JS
    N Engl J Med; 2006 Mar; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890
    [No Abstract]   [Full Text] [Related]  

  • 4. Global transmission of oseltamivir-resistant influenza.
    Moscona A
    N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
    Takano R; Kiso M; Igarashi M; Le QM; Sekijima M; Ito K; Takada A; Kawaoka Y
    J Infect Dis; 2013 Jan; 207(1):89-97. PubMed ID: 23053629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oseltamivir resistance during treatment of influenza A (H5N1) infection.
    de Jong MD; Tran TT; Truong HK; Vo MH; Smith GJ; Nguyen VC; Bach VC; Phan TQ; Do QH; Guan Y; Peiris JS; Tran TH; Farrar J
    N Engl J Med; 2005 Dec; 353(25):2667-72. PubMed ID: 16371632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of antiviral resistance of influenza viruses.
    Monto AS
    Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
    Abed Y; Baz M; Boivin G
    J Infect Dis; 2009 Jan; 199(2):180-3. PubMed ID: 19046066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.
    Lackenby A; Democratis J; Siqueira MM; Zambon MC
    Antivir Ther; 2008; 13(6):809-20. PubMed ID: 18839782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
    Baz M; Abed Y; Papenburg J; Bouhy X; Hamelin ME; Boivin G
    N Engl J Med; 2009 Dec; 361(23):2296-7. PubMed ID: 19907034
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
    Enserink M
    Science; 2009 Feb; 323(5918):1162-3. PubMed ID: 19251605
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bird flu: increased resistance to oseltamivir. Are our weapons already blunt? (interview by Dr. Elke Oberhofer)].
    Nothdurft HD
    MMW Fortschr Med; 2006 Oct; 148(41):22. PubMed ID: 17190255
    [No Abstract]   [Full Text] [Related]  

  • 14. [Naturally occurring oseltamivir resistance in influenza A].
    Madsen L; Nielsen A; Lundgren J
    Ugeskr Laeger; 2010 Aug; 172(32):2165-7. PubMed ID: 20696118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.
    Malaisree M; Rungrotmongkol T; Nunthaboot N; Aruksakunwong O; Intharathep P; Decha P; Sompornpisut P; Hannongbua S
    Amino Acids; 2009 Oct; 37(4):725-32. PubMed ID: 19002747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oseltamivir resistance: what does it mean clinically?
    Baum SG
    Clin Infect Dis; 2009 Dec; 49(12):1836-7. PubMed ID: 19911972
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".
    Rungrotmongkol T; Malaisree M; Udommaneethanakit T; Hannongbua S
    Biophys Chem; 2009 Apr; 141(1):131-2; author reply 133. PubMed ID: 19231807
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuraminidase inhibitors and their role in avian and pandemic influenza.
    Crusat M; de Jong MD
    Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
    Duwe S; Schweiger B
    J Virol Methods; 2008 Nov; 153(2):134-41. PubMed ID: 18725246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza.
    Hill AW; Guralnick RP; Wilson MJ; Habib F; Janies D
    Infect Genet Evol; 2009 Mar; 9(2):169-78. PubMed ID: 19022400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.